Degree of immune suppression and risk of HIV-related Hodgkin lymphoma: Time points matter

Blood

Volumn 114, Issue 11, 2009, Pages 2354-

  Dolcetti, Riccardo ^a   De Paoli, Paolo ^a   Serraino, Diego ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER;

CANCER RISK; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTOPENIA; PRIORITY JOURNAL; VIRUS LOAD; ADULT; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; NOTE; SWITZERLAND;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; SWITZERLAND;

EID: 70349569070     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-226613     Document Type: Letter

References (5)

1. Clifford GM, Rickenbach M, Lise M, et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood. 2009;113:5737-5742.
2. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791. (Pubitemid 44864560)
3. Romagnani S, Del Prete GF, Maggi E, et al. Displacement of T lymphocytes with the "helper/inducer" phenotype from peripheral blood lymphoid organs in untreated patients with Hodgkin's disease. Scand J Haematol. 1983;31:305-314.
4. van den BA, Visser L, Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells: a possible explanation for the characteristic Tcell infiltrate in Hodgkin's lymphoma. Am J Pathol. 1999;154:1685-1691. (Pubitemid 29262850)
5. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol. 2008;8:247-258.